Literature DB >> 17652184

Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes.

Aibin He1, Liuluan Zhu, Nishith Gupta, Yongsheng Chang, Fude Fang.   

Abstract

Micro-RNAs (miRNAs) have been suggested to play pivotal roles in multifarious diseases associated with the posttranscriptional regulation of protein-coding genes. In this study, we aimed to investigate the function of miRNAs in type 2 diabetes mellitus. The miRNAs expression profiles were examined by miRNA microarray analysis of skeletal muscles from healthy and Goto-Kakizaki rats. We identified four up-regulated miRNAs, and 11 miRNAs that were down-regulated relative to normal individuals. Among induced miRNAs were three paralogs of miR-29, miR-29a, miR-29b, and miR-29c. Northern blotting further confirmed their elevated expression in three important target tissues of insulin action: muscle, fat, and liver of diabetic rats. Adenovirus-mediated overexpression of miR-29a/b/c in 3T3-L1 adipocytes could largely repress insulin-stimulated glucose uptake, presumably through inhibiting Akt activation. The increase in miR-29 level caused insulin resistance, similar to that of incubation with high glucose and insulin in combination, which, in turn, induced miR-29a and miR-29b expression. In this paper, we demonstrate that Akt is not the direct target gene of miR-29 and that the negative effects of miR-29 on insulin signaling might be mediated by other unknown intermediates. Taken together, these data reveal the crucial role of miR-29 in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652184     DOI: 10.1210/me.2007-0167

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  162 in total

Review 1.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  Minireview: microRNA function in pancreatic β cells.

Authors:  Sabire Ozcan
Journal:  Mol Endocrinol       Date:  2014-12

3.  Metalloprotease-disintegrin ADAM12 expression is regulated by Notch signaling via microRNA-29.

Authors:  Hui Li; Emilia Solomon; Sara Duhachek Muggy; Danqiong Sun; Anna Zolkiewska
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

4.  Follicle-stimulating hormone regulation of microRNA expression on progesterone production in cultured rat granulosa cells.

Authors:  Nan Yao; Bai-Qing Yang; Yu Liu; Xin-Yu Tan; Cai-Ling Lu; Xiao-Hua Yuan; Xu Ma
Journal:  Endocrine       Date:  2010-08-24       Impact factor: 3.633

Review 5.  Novel Mediators of Adipose Tissue and Muscle Crosstalk.

Authors:  Ira Indrakusuma; Henrike Sell; Jürgen Eckel
Journal:  Curr Obes Rep       Date:  2015-12

6.  Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression.

Authors:  Lacey J Luense; Almudena Veiga-Lopez; Vasantha Padmanabhan; Lane K Christenson
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

Review 7.  miRNAs: effectors of environmental influences on gene expression and disease.

Authors:  Alice Hudder; Raymond F Novak
Journal:  Toxicol Sci       Date:  2008-02-16       Impact factor: 4.849

Review 8.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

Review 9.  Potential regulatory functions of microRNAs in the ovary.

Authors:  Tannaz Toloubeydokhti; Orhan Bukulmez; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

10.  MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes.

Authors:  Sadakatsu Ikeda; Aibin He; Sek Won Kong; Jun Lu; Rafael Bejar; Natalya Bodyak; Kyu-Ho Lee; Qing Ma; Peter M Kang; Todd R Golub; William T Pu
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.